Home
About SinovacProductsPipelineInvestorsContact Us
 
 
  SITEMAP 中文版
  Pipeline
R&D Strategy
EV71 Vaccine
Pneumococcal Conjugate Vaccine
Hib Vaccine
Meningitis Vaccine
Japanese Encephalitis Vaccine
SARS Vaccine
Home Page
 
 
Pneumococcal Conjugate Vaccine

Pneumococcal diseases are a major public health problem all over the world. Infections caused by pneumococci are a major cause of morbidity and mortality all over the world. Pneumonia, febrile bacteraemia and meningitis are the most common manifestations of invasive pneumococcal disease, whereas bacterial spread within the respiratory tract may result in middle-ear infection, sinusitis or recurrent bronchitis. Based on available data, acute respiratory infections kill an estimated 2.6 million children under five years of age annually. The pneumococcus causes over 1 million of these deaths, most of which occur in developing countries, where the pneumococcus is probably the most important pathogen of early infancy. (http://www.who.int/vaccines/en/pneumococcus.shtml)
 
Currently no local producer has the license to supply this vaccine.

 
 
Copyright © 2009 Sinovac Biotech Ltd. All rights reserved.